Search
Fibronectin
go.drugbank.com/drugs/DB15150InvestigationalFibronectin is under investigation in clinical trial NCT01812239 (Vaginal Progesterone in Twins With Short Cervix).
Nerinetide
go.drugbank.com/drugs/DB12595InvestigationalNa 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling Therapy).
Clopenthixol
go.drugbank.com/drugs/DB13841InvestigationalClopenthixol is a thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors.
INO-4995
go.drugbank.com/drugs/DB17834ExperimentalINO-4995 is an inositol tetrakisphosphate analog being investigated for Cystic Fibrosis.[A259781]
Novolimus
go.drugbank.com/drugs/DB19085InvestigationalNovolimus is under investigation in clinical trial NCT04483791 (Dynamx Bioadaptor Hong Kong Registry).
Lixudebart
go.drugbank.com/drugs/DB19244InvestigationalLixudebart, an investigational first-in-class monoclonal antibody, aims to reverse fibrosis.[L50833]
Formononetin
go.drugbank.com/drugs/DB15335ExperimentalFormononetin is under investigation in clinical trial NCT02174666 (Isoflavone Treatment for Postmenopausal Osteopenia.).
Cortivazol
go.drugbank.com/drugs/DB13003InvestigationalCortivazol is under investigation in clinical trial NCT00804895 (Cluster Headache Cortivazol Injection (CHCI)).
Stibophen
go.drugbank.com/drugs/DB13236ExperimentalStibophen is used in the treatment of schistosomiasis, a disease of parasitic flatworms.
Ancriviroc
go.drugbank.com/drugs/DB19773ExperimentalAncriviroc is a small molecule drug. The usage of the INN stem '-viroc' in the name indicates that Ancriviroc is a CCR5 (Chemokine CC motif receptor 5) receptor antagonist.